Stocks
Health Care
rare
Ultragenyx Pharmaceutical
NASDAQ: RARE
-0.27 (-1.25%)
21.795
USD
At close at Mar 04, 21:38 UTC
Income Statement
Revenue
560.23M
Gross Profit
483.50M
Operating Income
-541.76M
Pretax Income
-576.72M
Net Income
-569.18M
EBITDA
-532.04M
EBIT
-567.59M
Earnings Per Share
-6.329999999999999
Balance Sheet
Cash & Cash Equivalents
229.32M
Total Debt
920.30M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
297.20M
Book Value Per Share
3.4
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.